Press Releases Biosergen AB

Equities

BIOSGN

SE0016013460

Delayed Nasdaq Stockholm Other stock markets 03:10:47 2024-04-29 am EDT			5-day change	1st Jan Change
0.33 ^SEK	-3.23%		-15.17%	-61.25%

Apr. 09	Biosergen to Issue New Units as Compensation Under Rights Issue	MT
Mar. 27	Biosergen Raises SEK26.4 Million via Rights Issue	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Conversion of paid subscribed units and first day of trading with warrants of series TO3	Apr. 16	AQ
Biosergen resolves on a directed issue to underwriters in connection with the completed rights issue	Apr. 09	AQ
Biosergen announces the outcome in the rights issue	Mar. 26	AQ
BioStock Investor Pitch: Biosergen	Mar. 18	AQ
Members of the board of directors and management subscribe in ongoing rights issue	Mar. 15	AQ
Research update Biosergen: Rights issue to fund crucial step for lead project	Mar. 13	AQ
BioStock: Rights issue to give Biosergen first in-human efficacy data	Mar. 12	AQ
BioStock: Biosergen attacks invisible threat of fungal infections	Mar. 08	AQ
Carlsquare Equity Research interview with Biosergen	Mar. 07	AQ
Biosergen CEO to BioStock: "Positive data give us a strong value proposition"	Mar. 07	AQ
Biosergen publishes prospectus due to rights issue of units	Mar. 05	AQ
Bulletin from the extraordinary general meeting in Biosergen AB (publ)	Mar. 01	AQ
Biosergen publishes interim report for fourth quarter 2023	Feb. 29	AQ
Biosergen receives regulatory approval to test lead candidate BSG005 in patients with invasive fungal infection.	Feb. 12	AQ
Mrkt BUZZ, Biosergen: Rights issue to fund the next clinical step	Feb. 02	AQ
Notice of Extraordinary general meeting in Biosergen AB	Jan. 30	AQ
Biosergen carries out a rights issue of units of approximately SEK 40.5 million, and secures bridge loan	Jan. 30	AQ
Research Update Biosergen: Licensing deal with Alkem and CTA submission	Jan. 16	AQ
Biosergen Announces Leadership Transition: Peder M. Andersen to Step Down as CEO, Tine Olesen Appointed as Successor	Jan. 12	AQ
Biosergen - Indian collaboration gives boost - Mangold Insight Analys	Jan. 12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Biosergen AB

Equities

BIOSGN

SE0016013460

Press Releases

Filters